Form 8-K - Current report:
SEC Accession No. 0000950123-08-004313
Filing Date
2008-04-18
Accepted
2008-04-17 18:32:41
Documents
2
Period of Report
2008-04-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y54970e8vk.htm 8-K 19521
2 EX-3.I: AMENDED AND RESTATED CERTIFICATE OF INCORPORATION y54970exv3wi.htm EX-3.I 5364
  Complete submission text file 0000950123-08-004313.txt   26706
Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Filer) CIK: 0001012270 (see all company filings)

EIN.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28308 | Film No.: 08763085
SIC: 2834 Pharmaceutical Preparations